AURA — AURA BIOSCIENCES Cashflow Statement
0.000.00%
Last trade - 00:00- $357.42m
- $131.27m
- 29
- 29
- 54
- 31
Annual cashflow statement for AURA BIOSCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.2 | -22.2 | -35.3 | -58.8 | -76.4 |
| Depreciation | |||||
| Non-Cash Items | 0.561 | 0.733 | 2.33 | 6.09 | 6.83 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.46 | -3.68 | -0.315 | -3.1 | 4.44 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -20.7 | -24.3 | -32.4 | -54.6 | -63.8 |
| Capital Expenditures | -2.22 | -0.771 | -2.13 | -1.09 | -0.709 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -66.8 | -113 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.22 | -0.771 | -2.13 | -67.9 | -114 |
| Financing Cash Flow Items | — | — | -0.015 | 0 | 0.128 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 39.7 | 10 | 166 | 95.6 | 97.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.8 | -15.1 | 132 | -26.8 | -80.5 |